Table of Contents Table of Contents
Previous Page  310 / 364 Next Page
Information
Show Menu
Previous Page 310 / 364 Next Page
Page Background

Share capital and share ownership

7.3 Authorization to issue securities that give access to the share capital

DANONE

REGISTRATION DOCUMENT 2015

310

7.3 AUTHORIZATION TO ISSUE SECURITIES THAT GIVE ACCESS

TO THE SHARE CAPITAL

Summary of financial authorizations in force as of December 31, 2015

The existing authorizations for the issuance of ordinary shares and securities, with or without preferential subscription rights, in force as

of December 31, 2015 are provided in the following table.

All these authorizations were approved by the Shareholders' Meeting of April 29, 2015 for a period of 26 months, i.e. until June 29, 2017,

except the authorization to grant Group performance shares, which expired on December 31, 2015.

Maximum amounts of share capital authorized

Authorization type

Individual

maximum amounts

authorized

Use in 2015

Balance available

as of December 31,

2015

(nominal amount)

(nominal amount

or percentage of

share capital)

(nominal amount

or percentage of

share capital)

Maximum

amount applicable

to all dilutive and

non-dilutive

issuances:

€56.3 million

(approximately 34.4%

(a)

of share capital)

Maximum amount

applicable to

non-dilutive

issuances:

€56.3 million

(approximately

34.4%

(a)

of share capital)

Capital increase

with preferential

subscription

rights for

shareholders

€56.3 million

(approximately

34.4%

(a)

of share capital)

(b)

_

€56.3 million

Maximum amount

applicable to

dilutive

issuances:

€16 million

(approximately

9.8%

(a)

of share capital)

Capital

increase without

preferential

subscription right

but with a right

of first refusal for

shareholders

€16 million

(approximately

9.8%

(a)

of

share capital)

(b)

_

€16 million

Overallotment

(as a % of initial

issuance)

15%

(b)

_

_

Public exchange

offer initiated by

the Company

€16 million

(approximately

9.8%

(a)

of

share capital)

(b)

_

€16 million

Contributions

in kind

10% of share

capital

10% of

share capital

Capital increase

reserved for

employees and/

or executives

€3.2 million

(approximately

2.0%

(a)

of share

capital)

€209,513

€3.2 million

(c)

Grants of Group

performance

shares (GPS)

0.2% of share

capital as of the

closure of the

Shareholders'

Meeting

645,372 shares

granted

(approximately

0.1% of share

capital)

0.1% of share

capital as of the

closure of the

Shareholders'

Meeting

_

_ Incorporation of

reserves, earn-

ings, premiums or

other sums

€40.2 million

(approximately

24.6%

(a)

of share

capital)

€40.2 million

(a)Thepercentageofsharecapital iscalculatedfor informationpurposesonlyonthebasisofthesharecapitalasofDecember31,2015 (unlessotherwise indicated).

(b) All issuances of securities representing debts pursuant to these authorizations ((i) capital increase with preferential subscription right, (ii) capital increase

without preferential subscription right but with priority right for shareholders, (iii) over-allotment option, and (iv) public tender offer initiated by the Company)

may not exceed a ceiling representing a principal amount of €2 billion (or the counter-value of this amount).

(c) Thecapital increasereservedforGroupemployeesapprovedbytheBoardofDirectorsonFebruary19,2015and implemented inJune2015usedtheauthorization

approved by the Shareholders' Meeting held on April 25, 2013 (and not the authorization approved by the Shareholders' Meeting held on April 29, 2015). The

nominal amount of the newcapital increase reserved for employees, approved by theBoard of Directors on February 22, 2016 and to be completed in June 2016,

will be deducted from the maximum amount of €3.2 million approved by the Shareholdersʼ Meeting of April 29, 2015.